Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -72.15%-57.95M | -134.46%-16.39M | -63.56%-30.67M | -53.93%-9.24M | 13.67%-1.66M | -43.64%-33.66M | -42.45%-6.99M | -42.63%-18.75M | -43.36%-6M | -60.63%-1.92M |
| Net income from continuing operations | -73.51%-54.18M | -121.06%-10.93M | -115.71%-29.46M | -22.34%-10.4M | 17.86%-3.38M | -30.40%-31.23M | -48.75%-4.95M | -25.40%-13.66M | -24.22%-8.5M | -42.81%-4.12M |
| Operating gains losses | -572.87%-98.91K | 1,800.00%42.5K | 145.45%67.5K | ---176.41K | -695.79%-32.5K | --20.92K | ---2.5K | --27.5K | --0 | ---4.08K |
| Depreciation and amortization | 70.96%1.11M | 46.02%319.92K | 34.54%299.39K | 95.37%266.47K | 218.41%221.16K | 174.21%647.47K | 190.60%219.09K | 319.52%222.53K | 139.56%136.39K | 36.87%69.46K |
| Remuneration paid in stock | -14.71%143.73K | -99.99%2 | --0 | ---- | ---- | -10.38%168.51K | -92.17%14.72K | --0 | ---- | ---- |
| Unrealized gains and losses of investment securities | -94.22%618 | -1,571.48%-264.83K | 860.06%168.68K | ---- | ---- | --10.7K | ---15.84K | --17.57K | ---- | ---- |
| Remuneration paid in stock | -14.34%8.64M | 48.04%3.2M | -6.84%2.02M | -22.70%2.15M | -57.40%1.27M | 79.42%10.09M | 71.04%2.16M | 92.13%2.17M | 72.30%2.78M | 84.21%2.97M |
| Other non cashItems | -4.56%-12.58M | 20.94%-614.48K | 6.17%-7.43M | -31.64%-4M | -79.58%-540.31K | -100.67%-12.03M | -43.40%-777.25K | -111.87%-7.92M | -106.80%-3.04M | -20.98%-300.88K |
| Change In working capital | 26.64%-985.82K | -123.28%-8.14M | 853.98%3.66M | 8.99%2.68M | 248.49%807.42K | -392.73%-1.34M | -41.97%-3.64M | 28.74%383.96K | 0.10%2.46M | -301.57%-543.77K |
| -Change in receivables | 61.66%-489.76K | -2,463.34%-299.68K | -16.58%-897.19K | 5.48%-488.15K | 5,786.84%1.2M | -390.05%-1.28M | -101.94%-11.69K | -134.34%-769.58K | -80.92%-516.47K | -95.52%20.3K |
| -Change in prepaid assets | -18.96%-597.22K | 92.27%-24.91K | -5.04%716.2K | -206.42%-1.03M | 56.37%-261.17K | -810.19%-502.04K | -263.95%-322.43K | 447.50%754.21K | -471.46%-335.27K | -74,178.09%-598.55K |
| -Change in payables and accrued expense | 8.39%668.41K | -131.54%-7.25M | 862.60%3.84M | 26.72%4.2M | -467.41%-126.67K | 1,285.30%616.69K | 7.00%-3.13M | -52.67%399.32K | 24.83%3.31M | 118.73%34.48K |
| -Change in other current liabilities | -213.27%-567.25K | ---- | ---- | ---- | ---- | ---181.08K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -72.15%-57.95M | -134.46%-16.39M | -63.56%-30.67M | -53.93%-9.24M | 13.67%-1.66M | -43.64%-33.66M | -42.45%-6.99M | -42.63%-18.75M | -43.36%-6M | -60.63%-1.92M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 78.66%-1.05M | -342.27%-172.81K | 68.12%-358.2K | 92.40%-270.46K | 20.66%-250K | -96.98%-4.93M | 107.97%71.33K | -1.12M | -207.42%-3.56M | 29.66%-315.12K |
| Net PPE purchase and sale | 81.66%-794.67K | -309.45%-149.4K | 70.20%-334.79K | 90.34%-310.48K | --0 | -95.01%-4.33M | 107.97%71.33K | ---1.12M | -184.98%-3.22M | 67.11%-65.12K |
| Net business purchase and sale | 0.00%-250K | --0 | --0 | --0 | 0.00%-250K | 0.00%-250K | --0 | --0 | --0 | 0.00%-250K |
| Net investment purchase and sale | 129.62%93.43K | --0 | --2 | ---- | ---- | ---315.39K | --0 | --0 | ---- | ---- |
| Net other investing changes | -234.10%-100.23K | ---23.42K | ---23.41K | ---- | ---- | 0.00%-30K | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 78.66%-1.05M | -342.27%-172.81K | 68.12%-358.2K | 92.40%-270.46K | 20.66%-250K | -96.98%-4.93M | 107.97%71.33K | ---1.12M | -207.42%-3.56M | 29.66%-315.12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 159.08%119.73M | 5,785.45%1.7M | 2,929.15%98.07M | -35.11%19.58M | -96.97%387.36K | 16.01%46.22M | -98.35%28.8K | -80.55%3.24M | 11,036.75%30.18M | -39.71%12.77M |
| Net common stock issuance | 285.46%116.29M | ---13.19K | 11,625,428.13%97.54M | ---- | ---- | -12.94%30.17M | --0 | -100.01%-839 | --30.17M | --0 |
| Proceeds from stock option exercised by employees | -78.56%3.44M | 5,831.23%1.71M | -83.65%529.54K | 7,724.17%815.2K | -96.97%387.36K | 209.51%16.05M | -98.35%28.8K | 196.15%3.24M | -96.16%10.42K | 515.20%12.77M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 159.08%119.73M | 5,785.45%1.7M | 2,929.15%98.07M | -35.11%19.58M | -96.97%387.36K | 16.01%46.22M | -98.35%28.8K | -80.55%3.24M | 11,036.75%30.18M | -39.71%12.77M |
| Net cash flow | ||||||||||
| Beginning cash position | 21.30%43.42M | 136.57%119.01M | -22.37%51.97M | -9.56%41.9M | 21.30%43.42M | 63.48%35.79M | 26.24%50.31M | 84.15%66.94M | 11.82%46.33M | 63.48%35.79M |
| Current changes in cash | 696.55%60.73M | -115.77%-14.86M | 503.02%67.04M | -51.15%10.07M | -114.45%-1.52M | -45.15%7.62M | -69.79%-6.89M | -575.37%-16.64M | 506.21%20.62M | -46.08%10.53M |
| End cash Position | 139.87%104.15M | 139.87%104.15M | 136.57%119.01M | -22.37%51.97M | -9.56%41.9M | 21.30%43.42M | 21.30%43.42M | 26.24%50.31M | 84.15%66.94M | 11.82%46.33M |
| Free cash from | -54.56%-58.75M | -139.04%-16.53M | -55.99%-31M | -3.62%-9.55M | 17.04%-1.66M | -48.14%-38.01M | -19.23%-6.92M | -51.18%-19.87M | -73.42%-9.22M | -43.42%-2M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.